申请人:Eisai Co., Ltd.
公开号:US04596826A1
公开(公告)日:1986-06-24
Described herein are novel carboxylic acid amide compounds or carboximide compounds represented by the general formula: ##STR1## wherein Z represents a group of the formula (1) or (2): ##STR2## wherein R.sup.1 and R.sup.2 are hydrogen atom or methyl group, respectively; Xs, which may be the same or different, are hydrogen atom, a lower alkyl, lower alkoxy, halo, or alkyl halide group, respectively, and n represents an integer of 0 to 2, and their pharmaceutically acceptable salts; process for the production thereof; and medicines containing the same. The novel compounds are useful as treating, preventing and improving agents for diseases attended with cerebral dysfunction as well as various symptoms caused by the said diseases. Further, the compounds are useful for the improvement of neurosis of the stomach; and treatment and prevention for various constipation.
本文描述了一种新的羧酸酰胺化合物或羧酰亚胺化合物,其通式表示为:##STR1## 其中Z表示式(1)或(2)的一种基团:##STR2## 其中R.sup.1和R.sup.2分别表示氢原子或甲基基团;Xs可以相同或不同,分别表示氢原子、低级烷基、低级烷氧基、卤素或烷基卤素基团,n表示0至2的整数,以及其药学上可接受的盐;制备过程;以及含有它们的药物。这些新化合物可用作治疗、预防和改善伴随脑功能障碍的疾病的治疗剂、预防剂和改善剂,以及由所述疾病引起的各种症状。此外,该化合物对于改善胃神经症以及治疗和预防各种便秘也是有用的。